NCT04294641 2026-01-23
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
Clinical Trials
8 trialsNCT01503515 2024-10-16
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant
Children's Oncology Group
Phase 3 Completed
NCT04743544 2021-02-08
Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy
Dokuz Eylul University
Unknown
NCT04547335 2020-09-16
The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole
Dokuz Eylul University
Unknown
NCT00893555 2017-01-12
VORI911
University Medical Center Groningen
Phase 3 Completed
NCT01416025 2016-08-18
VoriTDM
Johns Hopkins University
Phase 4 Completed
NCT01148160 2014-04-10
Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy
Asan Medical Center
Terminated
NCT00904995 2012-08-07
Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis
M.D. Anderson Cancer Center
Phase 3 Completed